These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27566395)

  • 1. Label-free and high-sensitive detection of Kirsten rat sarcoma viral oncogene homolog and epidermal growth factor receptor mutation using Kelvin probe force microscopy.
    Jang K; Choi J; Park C; Na S
    Biosens Bioelectron; 2017 Jan; 87():222-228. PubMed ID: 27566395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly sensitive and selective detection of single-nucleotide polymorphisms using gold nanoparticle MutS enzymes and a micro cantilever resonator.
    Park C; Kang J; Baek I; You J; Jang K; Na S
    Talanta; 2019 Dec; 205():120154. PubMed ID: 31450442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual DNA microarray for detection of epidermal growth factor receptor (EGFR) gene mutations.
    Xue L; Fei JJ; Song Y; Xu RH; Bai YJ
    Scand J Clin Lab Invest; 2014 Nov; 74(8):693-9. PubMed ID: 25223598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR fluorescence in situ hybridization-positive lung adenocarcinoma: incidence of coexisting KRAS and BRAF mutations.
    Chiosea S; Shuai Y; Cieply K; Nikiforova MN; Dacic S
    Hum Pathol; 2010 Aug; 41(8):1053-60. PubMed ID: 20381121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma.
    Cai G; Wong R; Chhieng D; Levy GH; Gettinger SN; Herbst RS; Puchalski JT; Homer RJ; Hui P
    Cancer Cytopathol; 2013 Sep; 121(9):500-7. PubMed ID: 23495083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EGFR and KRAS Mutations in ALK-Positive Lung Adenocarcinomas: Biological and Clinical Effect.
    Sahnane N; Frattini M; Bernasconi B; Zappa F; Schiavone G; Wannesson L; Antonelli P; Balzarini P; Sessa F; Mazzucchelli L; Tibiletti MG; Martin V
    Clin Lung Cancer; 2016 Jan; 17(1):56-61. PubMed ID: 26381283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of epidermal growth factor receptor and KRAS mutations on clinical outcome in resected non-small cell lung cancer patients.
    Ragusa M; Vannucci J; Ludovini V; Bianconi F; Treggiari S; Tofanetti FR; Flacco A; Colella R; Sidoni A; Crinò L; Puma F
    Am J Clin Oncol; 2014 Aug; 37(4):343-9. PubMed ID: 23357969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kras gene codon 12 mutation detection enabled by gold nanoparticles conducted in a nanobioarray chip.
    Sedighi A; Li PC
    Anal Biochem; 2014 Mar; 448():58-64. PubMed ID: 24291640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer.
    Ludovini V; Bianconi F; Pistola L; Chiari R; Minotti V; Colella R; Giuffrida D; Tofanetti FR; Siggillino A; Flacco A; Baldelli E; Iacono D; Mameli MG; Cavaliere A; Crinò L
    J Thorac Oncol; 2011 Apr; 6(4):707-15. PubMed ID: 21258250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of cytology based molecular analysis to guide targeted therapy in advanced non-small-cell lung cancer.
    Li W; Zhang Z; Guo L; Qiu T; Ling Y; Cao J; Guo H; Zhao H; Li L; Ying J
    Oncotarget; 2016 Feb; 7(7):8332-40. PubMed ID: 26789109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zeptomole Biosensing of DNA with Flexible Selectivity Based on Acoustic Levitation of a Single Microsphere Binding Gold Nanoparticles by Hybridization.
    Miyagawa A; Harada M; Okada T
    ACS Sens; 2018 Sep; 3(9):1870-1875. PubMed ID: 30152225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ultrasensitive and simple fluorescence biosensor for detection of the Kras wild type by using the three-way DNA junction-driven catalyzed hairpin assembly strategy.
    Li Q; Zhou D; Pan J; Liu Z; Chen J
    Analyst; 2019 May; 144(9):3088-3093. PubMed ID: 30919845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of EGFR and KRAS mutation status from FNAs and core-needle biopsies of non-small cell lung cancer.
    Lozano MD; Labiano T; Echeveste J; Gurpide A; Martín-Algarra S; Zhang G; Sharma A; Palma JF
    Cancer Cytopathol; 2015 Apr; 123(4):230-6. PubMed ID: 25529460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-epidermal growth factor receptor monoclonal antibodies in metastatic colorectal cancer: a meta-analysis.
    Song QB; Wang Q; Hu WG
    World J Gastroenterol; 2015 Apr; 21(14):4365-72. PubMed ID: 25892888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extremely sensitive and wide-range silver ion detection via assessing the integrated surface potential of a DNA-capped gold nanoparticle.
    Lee D; Lee H; Lee G; Kim I; Lee SW; Kim W; Lee SW; Lee JH; Park J; Yoon DS
    Nanotechnology; 2019 Feb; 30(8):085501. PubMed ID: 30524017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gold-nanoparticle-based colorimetric discrimination of cancer-related point mutations with picomolar sensitivity.
    Valentini P; Fiammengo R; Sabella S; Gariboldi M; Maiorano G; Cingolani R; Pompa PP
    ACS Nano; 2013 Jun; 7(6):5530-8. PubMed ID: 23697628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-validation study for epidermal growth factor receptor and KRAS mutation detection in 74 blinded non-small cell lung carcinoma samples: a total of 5550 exons sequenced by 15 molecular French laboratories (evaluation of the EGFR mutation status for the administration of EGFR-TKIs in non-small cell lung carcinoma [ERMETIC] project--part 1).
    Beau-Faller M; Degeorges A; Rolland E; Mounawar M; Antoine M; Poulot V; Mauguen A; Barbu V; Coulet F; Prétet JL; Bièche I; Blons H; Boyer JC; Buisine MP; de Fraipont F; Lizard S; Olschwang S; Saulnier P; Prunier-Mirebeau D; Richard N; Danel C; Brambilla E; Chouaid C; Zalcman G; Hainaut P; Michiels S; Cadranel J
    J Thorac Oncol; 2011 Jun; 6(6):1006-15. PubMed ID: 21532509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR and KRAS mutations in Chinese patients with adenosquamous carcinoma of the lung.
    Jia XL; Chen G
    Lung Cancer; 2011 Dec; 74(3):396-400. PubMed ID: 21592614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A smart DNA-gold nanoparticle probe for detecting single-base changes on the platform of a quartz crystal microbalance.
    Li H; Xiao S; Yao D; Lam MH; Liang H
    Chem Commun (Camb); 2015 Mar; 51(22):4670-3. PubMed ID: 25690314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of EGFR and KRAS status in primary lung carcinoma and matched metastases.
    Monaco SE; Nikiforova MN; Cieply K; Teot LA; Khalbuss WE; Dacic S
    Hum Pathol; 2010 Jan; 41(1):94-102. PubMed ID: 19740513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.